Works by Chang Woon Choi

Results: 30

A preliminary clinical trial to evaluate 64Cu-NOTA-Trastuzumab as a positron emission tomography imaging agent in patients with breast cancer.

Published in:

EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00746-1

By:

Lee, Inki;
Lim, Ilhan;
Byun, Byung Hyun;
Kim, Byung Il;
Choi, Chang Woon;
Woo, Sang-Keun;
Kim, Kwang Il;
Lee, Kyo Chul;
Kang, Joo Hyun;
Seong, Min-Ki;
Kim, Hyun-Ah;
Noh, Woo Chul;
Lim, Sang Moo

Publication type:

Article

Technetium-99m-Labeled Antigranulocyte Antibody Bone Marrow Scintigraphy.

Published in:

Journal of Nuclear Medicine, 1995, v. 36, n. 10, p. 1800

By:

Kyung Han Lee;
June-Key Chung;
Chang Woon Choi;
Jae Min Jeong;
Dong Soo Lee;
Yung Jue Bang;
Myung Chul Lee;
Noe Kyung Kim;
Chang-Soon Koh

Publication type:

Article

Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET/MRI image deep learning.

Published in:

Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-77875-5

By:

Choi, Joon Ho;
Kim, Hyun-Ah;
Kim, Wook;
Lim, Ilhan;
Lee, Inki;
Byun, Byung Hyun;
Noh, Woo Chul;
Seong, Min-Ki;
Lee, Seung-Sook;
Kim, Byung Il;
Choi, Chang Woon;
Lim, Sang Moo;
Woo, Sang-Keun

Publication type:

Article

Gamma camera and optical imaging with a fusion reporter gene using human sodium/iodide symporter and monomeric red fluorescent protein in mouse model.

Published in:

International Journal of Radiation Biology, 2011, v. 87, n. 12, p. 1182, doi. 10.3109/09553002.2011.630440

By:

Kim, Kwang Il;
Park, Jae Jun;
Lee, Yong Jin;
Lee, Tae Sup;
Woo, Kwang Sun;
Song, Inho;
Kim, Kyeong Min;
Choi, Chang Woon;
Lim, Sang Moo;
Kang, Joo Hyun

Publication type:

Article

Prognostic Significance of Pretreatment F-FDG PET/CT in Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma Treated by Radioimmunotherapy Using 131I-Rituximab.

Published in:

Acta Haematologica, 2013, v. 130, n. 2, p. 74, doi. 10.1159/000346436

By:

Lim, Ilhan;
Park, Joon Yeun;
Kang, Hye Jin;
Hwang, Jae Pil;
Lee, Seung Sook;
Kim, Kyeong Min;
Choi, Tae Hyun;
Yang, Sung Hyun;
Kim, Byung Il;
Choi, Chang Woon;
Lim, Sang Moo

Publication type:

Article

Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma.

Published in:

PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0153281

By:

Hwang, Jae Pil;
Lim, Ilhan;
Kong, Chang-Bae;
Jeon, Dae Geun;
Byun, Byung Hyun;
Kim, Byung Il;
Choi, Chang Woon;
Lim, Sang Moo

Publication type:

Article

Radioimmunotherapy with (131)I-rituximab as consolidation therapy for patients with diffuse large B-cell lymphoma.

Published in:

2016

By:

Shin, Dong-Yeop;
Byun, Byung;
Kim, Kyeong;
Kang, Joo;
Lim, Ilhan;
Kim, Byung;
Lee, Seung-Sook;
Choi, Chang;
Kang, Hye;
Lim, Sang;
Byun, Byung Hyun;
Kim, Kyeong Min;
Kang, Joo Hyun;
Kim, Byung Il;
Choi, Chang Woon;
Kang, Hye Jin;
Lim, Sang Moo

Publication type:

journal article

Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma.

Published in:

2013

By:

Kang, Hye Jin;
Lee, Seung-Sook;
Byun, Byung Hyun;
Kim, Kyeong Min;
Lim, Ilhan;
Choi, Chang Woon;
Suh, Cheolwon;
Kim, Won Seog;
Nam, Seung-Hyun;
Lee, Soon Il;
Eom, Hyeon Seok;
Shin, Dong-Yeop;
Lim, Sang Moo

Publication type:

journal article

Intracavitary Radiation Therapy for Recurrent Cystic Brain Tumors with Holmium-166-Chico : A Pilot Study.

Published in:

Journal of Korean Neurosurgical Society, 2013, v. 54, n. 3, p. 175, doi. 10.3340/jkns.2013.54.3.175

By:

Eun Jin Ha;
Ho-Shin Gwak;
Chang Hun Rhee;
Sang Min Youn;
Chang-Woon Choi;
Gi Jeong Cheon

Publication type:

Article

Initial Metabolic Tumor Volume Measured by 18F-FDG PET/CT Can Predict the Outcome of Osteosarcoma of the Extremities.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 10, p. 1725, doi. 10.2967/jnumed.112.117697

By:

Byung Hyun Byun;
Chang-Bae Kong;
Jihyun Park;
Youngseok Seo;
Ilhan Lim;
Chang Woon Choi;
Wan Hyeong Cho;
Dae-Geun Jeon;
Jae-Soo Koh;
Soo-Yong Lee;
Sang Moo Lim

Publication type:

Article

Combination of 18F-FDG PET/CT and Diffusion-Weighted MR Imaging as a Predictor of Histologic Response to Neoadjuvant Chemotherapy: Preliminary Results in Osteosarcoma.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 7, p. 1053, doi. 10.2967/jnumed.112.115964

By:

Byung Hyun Byun;
Chang-Bae Kong;
Ilhan Lim;
Chang Woon Choi;
Won Seok Song;
Wan Hyeong Cho;
Dae-Geun Jeon;
Jae-Soo Koh;
Soo-Yong Lee;
Sang Moo Lim

Publication type:

Article

Different Glucose Uptake and Glycolytic Mechanisms Between Hepatocellular Carcinoma and Intrahepatic Mass-Forming Cholangiocarcinoma with Increased 18F-FDG Uptake.

Published in:

Journal of Nuclear Medicine, 2005, v. 46, n. 10, p. 1753

By:

Jong Doo Lee;
Woo Ick Yang;
Young Nyun Park;
Kyung Sik Kim;
Jin Sub Choi;
Mijin Yun;
Dooheun Ko;
Tae-Sung Kim;
Cho, Arthur E. H.;
Hye Mi Kim;
Kwang-Hyub Han;
Seung-Soon Im;
Yong-Ho Ahn;
Chang Woon Choi;
Jeon Han Park

Publication type:

Article

Overexpression of Glut1 in Lymphoid Follicles Correlates with False-Positive 18F-FDG PET Results in Lung Cancer Staging.

Published in:

Journal of Nuclear Medicine, 2004, v. 45, n. 6, p. 999

By:

Jin-Haeng Chung;
Kyung-Ja Cho;
Seung-Sook Lee;
Hee Jong Baek;
Jong-Ho Park;
Gi Jeong Cheon;
Chang-Woon Choi;
Sang Moo Lim

Publication type:

Article

Detection of Early Recurrence with 18F-FDG PET in Patients with Cervical Cancer.

Published in:

Journal of Nuclear Medicine, 2003, v. 44, n. 3, p. 347

By:

Sang-Young Ryu;
Moon-Hong Kim;
Suck-Chul Choi;
Chang-Woon Choi;
Kyung-Hee Lee

Publication type:

Article

Value of FDG PET in Papillary Thyroid Carcinoma with Negative 131I Whole-Body Scan.

Published in:

Journal of Nuclear Medicine, 1999, v. 40, n. 6, p. 986

By:

June-Key Chung;
Young So;
Jae Sung Lee;
Chang Woon Choi;
Sang Moo Lim;
Dong Soo Lee;
Sung Woon Hong;
Yeo Kyu Youn;
Myung Chul Lee;
Bo Youn Cho

Publication type:

Article

Crossed-Cerebellar Diaschisis in Cerebral Infarction: Technetium-99m-HMPAO SPECT and MRI.

Published in:

Journal of Nuclear Medicine, 1997, v. 38, n. 1, p. 14

By:

Sang Eun Kim;
Chang Woon Choi;
Byung-Woo Yoon;
June-Key Chung;
Jae Kyu Roh;
Myung Chul Lee;
Chang-Soon Koh

Publication type:

Article

The role of 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using 131I-rituximab as consolidation therapy.

Published in:

PLoS ONE, 2022, v. 17, n. 9, p. 1, doi. 10.1371/journal.pone.0273839

By:

Choi, Joon Ho;
Lim, Ilhan;
Byun, Byung Hyun;
Kim, Byung Il;
Choi, Chang Woon;
Kang, Hye Jin;
Shin, Dong-Yeop;
Lim, Sang Moo

Publication type:

Article

Comparisons of 131I-rituximab treatment responses in patients with aggressive lymphoma and indolent lymphoma.

Published in:

2019

By:

Lee, Inki;
Byun, Byung Hyun;
Lim, Ilhan;
Kim, Byung Il;
Choi, Chang Woon;
Kim, Kyeong Min;
Shin, Dong-Yeop;
Kang, Hye Jin;
Lim, Sang Moo

Publication type:

journal article

An enhanced treatment effect can be expected from a higher serum thyroglobulin level after radioactive iodine therapy.

Published in:

2019

By:

Choi, Joon Ho;
Lim, Ilhan;
Lee, Inki;
Byun, Byung Hyun;
Kim, Byung Il;
Choi, Chang Woon;
Lim, Sang Moo

Publication type:

journal article

Prediction of tumor differentiation using sequential PET/CT and MRI in patients with breast cancer.

Published in:

2018

By:

Choi, Joon Ho;
Lim, Ilhan;
Noh, Woo Chul;
Kim, Hyun-Ah;
Seong, Min-Ki;
Jang, Seonah;
Seol, Hyesil;
Moon, Hansol;
Byun, Byung Hyun;
Kim, Byung Il;
Choi, Chang Woon;
Lim, Sang Moo

Publication type:

journal article

A new method for apparent diffusion coefficient measurement using sequential (18)F-FDG PET and MRI: correlation with histological grade of invasive ductal carcinoma of the breast.

Published in:

2013

By:

Byun, Byung Hyun;
Noh, Woo Chul;
Lim, Ilhan;
Lee, Seung Sook;
Cho, A Ra;
Park, Ji Ae;
Kim, Kyeong Min;
Kim, Hyun-Ah;
Kim, Eun-Kyu;
Kim, Byung Il;
Choi, Chang Woon;
Lim, Sang Moo

Publication type:

journal article

A microdose clinical trial to evaluate [18F]Florastamin as a positron emission tomography imaging agent in patients with prostate cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 1, p. 95, doi. 10.1007/s00259-020-04883-y

By:

Lee, Inki;
Lim, Ilhan;
Byun, Byung Hyun;
Kim, Byung Il;
Choi, Chang Woon;
Woo, Sang-Keun;
Lee, Kyo Chul;
Kang, Joo Hyun;
Kil, Hee Seup;
Park, Chansoo;
Chi, Dae Yoon;
Park, Jongwook;
Song, Kanghyon;
Lim, Sang Moo

Publication type:

Article

Early response monitoring of neoadjuvant chemotherapy using [18F]FDG PET can predict the clinical outcome of extremity osteosarcoma.

Published in:

EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-019-0588-4

By:

Lee, Inki;
Byun, Byung Hyun;
Lim, Ilhan;
Kim, Byung Il;
Choi, Chang Woon;
Koh, Jae-Soo;
Song, Won Seok;
Cho, Wan Hyeong;
Kong, Chang-Bae;
Lim, Sang Moo

Publication type:

Article

A Phase II Study of 131I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma.

Published in:

Clinical Medicine Insights: Oncology, 2023, v. 17, p. 1, doi. 10.1177/11795549231218082

By:

Yoon Jung Jang;
Sang Moo Lim;
Inki Lee;
Byung Hyun Byun;
Ilhan Lim;
Byung Il Kim;
Chang Woon Choi;
Seung-Sook Lee;
Sung Hyun Yang;
Im Il Na;
Hyo-Rak Lee;
Dong-Yeop Shin;
Hye Jin Kang

Publication type:

Article

Tumor targeting of humanized fragment antibody secreted from transgenic rice cell suspension culture.

Published in:

Plant Molecular Biology, 2008, v. 68, n. 4-5, p. 413, doi. 10.1007/s11103-008-9379-4

By:

Shin-Young Hong;
Tae-Sup Lee;
Ju Kim;
Jae-Ho Jung;
Chang-Woon Choi;
Tae-Geum Kim;
Tae-Ho Kwon;
Yong-Suk Jang;
Moon-Sik Yang

Publication type:

Article

Radioimmunotherapy with 131I‐rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma.

Published in:

Asia Pacific Journal of Clinical Oncology, 2023, v. 19, n. 6, p. 690, doi. 10.1111/ajco.13932

By:

Jang, Yoon Jung;
Lim, Sang Moo;
Lee, Inki;
Byun, Byung Hyun;
Lim, Ilhan;
Kim, Byung Il;
Choi, Chang Woon;
Lee, Seung‐Sook;
Suh, Cheolwon;
Yoon, Dok Hyun;
Kim, Inho;
Nam, Seung‐Hyun;
Lee, Mark Hong;
Won, Jong Ho;
Kong, Jee Hyun;
Jeong, Seong Hyun;
Oh, Suk Joong;
Park, Keon Woo;
Han, Jae Joon;
Song, Moo‐Kon

Publication type:

Article

Clinical significance of 18F-FDG uptake by primary sites in patients with diffuse large B cell lymphoma in the head and neck: a pilot study.

Published in:

2008

By:

Byun BH;
Na II;
Cheon GJ;
Kang HJ;
Kim KM;
Lee SS;
Ryoo BY;
Choi CW;
Lim SM;
Yang SH;
Byun, Byung Hyun;
Na, Im Il;
Cheon, Gi Jeong;
Kang, Hye Jin;
Kim, Kyeong Min;
Lee, Seung-Sook;
Ryoo, Baek-Yeol;
Choi, Chang Woon;
Lim, Sang Moo;
Yang, Sung Hyun

Publication type:

journal article

Preparation of 3′-deoxy-3′-[18F]fluorothymidine ([18F]FLT) in ionic liquid, [bmim][OTf].

Published in:

Journal of Labelled Compounds & Radiopharmaceuticals, 2006, v. 49, n. 3, p. 287, doi. 10.1002/jlcr.1046

By:

Moon, Byung Seok;
Lee, Kyo Chul;
An, Gwang Il;
Chi, Dae Yoon;
Yang, Seung Dae;
Choi, Chang Woon;
Lim, Sang Moo;
Chun, Kwon Soo

Publication type:

Article

Efficient methods for the synthesis of 5-(4-[18F]fluorophenyl)-10,15,20- tris(3-methoxyphenyl)porphyrin as a potential imaging agent for tumor.

Published in:

Journal of Labelled Compounds & Radiopharmaceuticals, 2005, v. 48, n. 10, p. 749, doi. 10.1002/jlcr.992

By:

Kavali, Rajesh R.;
Chul Lee, Byung;
Seok Moon, Byung;
Dae Yang, Seung;
Soo Chun, Kwon;
Woon Choi, Chang;
Lee, Chang-Hee;
Yoon Chi, Dae

Publication type:

Article

A Phase II Study of 131 I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma.

Published in:

Clinical Medicine Insights: Oncology, 2023, p. 1, doi. 10.1177/11795549231218082

By:

Jang, Yoon Jung;
Lim, Sang Moo;
Lee, Inki;
Byun, Byung Hyun;
Lim, Ilhan;
Kim, Byung Il;
Choi, Chang Woon;
Lee, Seung-Sook;
Yang, Sung Hyun;
Na, Im Il;
Lee, Hyo-Rak;
Shin, Dong-Yeop;
Kang, Hye Jin

Publication type:

Article

Works by Chang Woon Choi

A preliminary clinical trial to evaluate 64Cu-NOTA-Trastuzumab as a positron emission tomography imaging agent in patients with breast cancer.

Technetium-99m-Labeled Antigranulocyte Antibody Bone Marrow Scintigraphy.

Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET/MRI image deep learning.

Gamma camera and optical imaging with a fusion reporter gene using human sodium/iodide symporter and monomeric red fluorescent protein in mouse model.

Prognostic Significance of Pretreatment F-FDG PET/CT in Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma Treated by Radioimmunotherapy Using <sup>131</sup>I-Rituximab.

Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma.

Radioimmunotherapy with (131)I-rituximab as consolidation therapy for patients with diffuse large B-cell lymphoma.

Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma.

Intracavitary Radiation Therapy for Recurrent Cystic Brain Tumors with Holmium-166-Chico : A Pilot Study.

Initial Metabolic Tumor Volume Measured by <sup>18</sup>F-FDG PET/CT Can Predict the Outcome of Osteosarcoma of the Extremities.

Combination of <sup>18</sup>F-FDG PET/CT and Diffusion-Weighted MR Imaging as a Predictor of Histologic Response to Neoadjuvant Chemotherapy: Preliminary Results in Osteosarcoma.

Different Glucose Uptake and Glycolytic Mechanisms Between Hepatocellular Carcinoma and Intrahepatic Mass-Forming Cholangiocarcinoma with Increased <sup>18</sup>F-FDG Uptake.

Overexpression of Glut1 in Lymphoid Follicles Correlates with False-Positive <sup>18</sup>F-FDG PET Results in Lung Cancer Staging.

Detection of Early Recurrence with <sup>18</sup>F-FDG PET in Patients with Cervical Cancer.

Value of FDG PET in Papillary Thyroid Carcinoma with Negative <sup>131</sup>I Whole-Body Scan.

Crossed-Cerebellar Diaschisis in Cerebral Infarction: Technetium-99m-HMPAO SPECT and MRI.

The role of <sup>18</sup>F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using <sup>131</sup>I-rituximab as consolidation therapy.

Comparisons of <sup>131</sup>I-rituximab treatment responses in patients with aggressive lymphoma and indolent lymphoma.

An enhanced treatment effect can be expected from a higher serum thyroglobulin level after radioactive iodine therapy.

Prediction of tumor differentiation using sequential PET/CT and MRI in patients with breast cancer.

A new method for apparent diffusion coefficient measurement using sequential (18)F-FDG PET and MRI: correlation with histological grade of invasive ductal carcinoma of the breast.

A microdose clinical trial to evaluate [18F]Florastamin as a positron emission tomography imaging agent in patients with prostate cancer.

Early response monitoring of neoadjuvant chemotherapy using [18F]FDG PET can predict the clinical outcome of extremity osteosarcoma.

A Phase II Study of 131I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma.

Tumor targeting of humanized fragment antibody secreted from transgenic rice cell suspension culture.

Radioimmunotherapy with <sup>131</sup>I‐rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma.

Clinical significance of 18F-FDG uptake by primary sites in patients with diffuse large B cell lymphoma in the head and neck: a pilot study.

Preparation of 3′-deoxy-3′-[<sup>18</sup>F]fluorothymidine ([<sup>18</sup>F]FLT) in ionic liquid, [bmim][OTf].

Efficient methods for the synthesis of 5-(4-[<sup>18</sup>F]fluorophenyl)-10,15,20- tris(3-methoxyphenyl)porphyrin as a potential imaging agent for tumor.

A Phase II Study of 131 I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma.